The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Oncol.
Sec. Molecular and Cellular Oncology
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1470173
This article is part of the Research Topic The Role of Post-translational Modifications in Cancer Biology View all 11 articles
Editorial: The Role of Post-translational Modifications in Cancer Biology
Provisionally accepted- 1 Central Drug Research Institute (CSIR), Lucknow, India
- 2 Indian Institute of Toxicology Research (CSIR), Lucknow, Uttar Pradesh, India
Keywords: Post translational modification (PTM, Ubiquitination, Phosphorylation, Cancer, Acetylation
Received: 25 Jul 2024; Accepted: 12 Aug 2024.
Copyright: © 2024 Srivastava, Tripathi and Trivedi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Arun K. Trivedi, Central Drug Research Institute (CSIR), Lucknow, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.